131 related articles for article (PubMed ID: 32794077)
1. Comparative Pharmacokinetics of Nimodipine in Rat Plasma and Tissues Following Intraocular, Intragastric, and Intravenous Administration.
Li F; Fei Q; Mao D; Si Q; Dai M; Ma Q; Zhang H; Bai L; He N
AAPS PharmSciTech; 2020 Aug; 21(6):234. PubMed ID: 32794077
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of Nimodipine after Intraocular Administration in Rats].
Li F; Mao D; Dai MM; Zhang HM; Ma Q; Bai LY; He N
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Feb; 41(1):57-62. PubMed ID: 30837043
[TBL] [Abstract][Full Text] [Related]
3. Intraocular administration of tetramethylpyrazine hydrochloride to rats: a direct delivery pathway for brain targeting?
Mao D; Li F; Ma Q; Dai M; Zhang H; Bai L; He N
Drug Deliv; 2019 Dec; 26(1):841-848. PubMed ID: 31401891
[TBL] [Abstract][Full Text] [Related]
4. Effect of natural borneol on the pharmacokinetics and distribution of nimodipine in mice.
Wu C; Liao Q; Yao M; Xu X; Zhou Y; Hou X; Xie Z
Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):17-24. PubMed ID: 23673491
[TBL] [Abstract][Full Text] [Related]
5. Effect of P-glycoprotein inhibitors erythromycin and cyclosporin A on brain pharmacokinetics of nimodipine in rats.
Liu XD; Zhang L; Xie L
Eur J Drug Metab Pharmacokinet; 2003; 28(4):309-13. PubMed ID: 14743973
[TBL] [Abstract][Full Text] [Related]
6. Distribution of nimodipine in brain following intranasal administration in rats.
Zhang QZ; Jiang XG; Wu CH
Acta Pharmacol Sin; 2004 Apr; 25(4):522-7. PubMed ID: 15066224
[TBL] [Abstract][Full Text] [Related]
7. Studies on differences of pharmacokinetic behavior and tissue distribution of nimodipine and its two enantiomers in rats using achiral and chiral liquid chromatography.
He LC; Wang SC
Yao Xue Xue Bao; 2003 Aug; 38(8):603-8. PubMed ID: 14628452
[TBL] [Abstract][Full Text] [Related]
8. Systemic and ocular pharmacokinetics of N-4-benzoylaminophenylsulfonylglycine (BAPSG), a novel aldose reductase inhibitor.
Sunkara G; Ayalasomayajula SP; Rao CS; Vennerstrom JL; DeRuiter J; Kompella UB
J Pharm Pharmacol; 2004 Mar; 56(3):351-8. PubMed ID: 15025860
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, tissue distribution, bioavailability, and excretion of nuciferine, an alkaloid from lotus, in rats by LC/MS/MS.
Wang F; Cao J; Hou X; Li Z; Qu X
Drug Dev Ind Pharm; 2018 Sep; 44(9):1557-1562. PubMed ID: 29909691
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tissue distribution evaluation of α-asaronol and its main metabolite in rats by HPLC method.
Sun Y; Bai Y; Zeng M; Chen X; Xie J; Li B; He X; Bai Y; Jia P; Meng X; Liang J; Wang S; Fan TP; Wu B; Zheng X
J Pharm Biomed Anal; 2019 Aug; 172():349-356. PubMed ID: 31085397
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
[TBL] [Abstract][Full Text] [Related]
12. Development and pharmacokinetics of nimodipine-loaded liposomes.
Wang Z; Deng Y; Zhang X; Wang T; Wu F
J Pharm Pharmacol; 2006 Sep; 58(9):1289-94. PubMed ID: 16945189
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics and brain distribution of NMD/TMP-nanoparticles].
He WJ; Hong Q; Liang J; He XW; Zhu FJ
Zhongguo Zhong Yao Za Zhi; 2016 Nov; 41(22):4254-4258. PubMed ID: 28933097
[TBL] [Abstract][Full Text] [Related]
14. Contribution of both olfactory and systemic pathways for brain targeting of nimodipine-loaded lipo-pluronics micelles: in vitro characterization and in vivo biodistribution study after intranasal and intravenous delivery.
Rashed HM; Shamma RN; Basalious EB
Drug Deliv; 2016 Nov; 24(1):181-187. PubMed ID: 28156162
[TBL] [Abstract][Full Text] [Related]
15. Nimodipine nanocrystals for oral bioavailability improvement: role of mesenteric lymph transport in the oral absorption.
Fu Q; Sun J; Ai X; Zhang P; Li M; Wang Y; Liu X; Sun Y; Sui X; Sun L; Han X; Zhu M; Zhang Y; Wang S; He Z
Int J Pharm; 2013 May; 448(1):290-7. PubMed ID: 23384726
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tissue distribution of olanzapine in rats.
Aravagiri M; Teper Y; Marder SR
Biopharm Drug Dispos; 1999 Nov; 20(8):369-77. PubMed ID: 10870093
[TBL] [Abstract][Full Text] [Related]
17. Absorption, elimination and cerebrospinal fluid concentrations of nimodipine in healthy beagle dogs receiving human intravenous and oral formulation.
Koskimäki J; Tarkia M; Ahtola-Sätilä T; Saloranta L; Laakso A; Frantzén J
Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):295-300. PubMed ID: 25652785
[TBL] [Abstract][Full Text] [Related]
18. Dose-response relationships with nimodipine against electroshock seizures in mice.
Sills GJ; Carswell A; Brodie MJ
Epilepsia; 1994; 35(2):437-42. PubMed ID: 8156970
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, bioavailability and tissue distribution of geniposide following intravenous and peroral administration to rats.
Wang F; Cao J; Hao J; Liu K
Biopharm Drug Dispos; 2014 Mar; 35(2):97-103. PubMed ID: 24122743
[TBL] [Abstract][Full Text] [Related]
20. Effects of the antioxidant baicalein on the pharmacokinetics of nimodipine in rats: a possible role of P-glycoprotein and CYP3A4 inhibition by baicalein.
Cho YA; Choi JS; Burm JP
Pharmacol Rep; 2011; 63(4):1066-73. PubMed ID: 22001996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
